Bagnasco, L <br/><br/>
Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors.  [electronic resource] 

 -  Current cancer drug targets  May 2012 
 - 303-15 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1873-5576 
<br/><br/><label>Standard No.: </label>10.2174/156800912800190929  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenomatous Polyposis Coli--drug therapy<br/>Angiogenesis Inhibitors--therapeutic use<br/>Animals<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Bevacizumab<br/>Biomarkers, Tumor--analysis<br/>Colorectal Neoplasms--drug therapy<br/>Female<br/>Humans<br/>Male<br/>Mice<br/>Neovascularization, Pathologic--drug therapy<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors